Skip to main content
. 2018 May 21;14(6):1271–1280. doi: 10.5114/aoms.2018.73398

Figure 6.

Figure 6

Diagrams presenting: A – the difference between the expression of the CD200 molecule (MFI) on CD19+ cells in gastric cancer patients and healthy controls (***p < 0.001 vs. control); B – the expression of the CD200R molecule (MFI) on CD19+ cells in gastric cancer patients and healthy controls (***p < 0.004 vs. control)